Simplex Trading’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,700
Closed -$1K 11128
2021
Q1
$1K Buy
4,700
+1,200
+34% +$850 ﹤0.01% 8614
2020
Q4
$1K Buy
3,500
+3,136
+862% +$1.58K ﹤0.01% 8206
2020
Q3
$0 Buy
364
+181
+99% +$130 ﹤0.01% 8887
2020
Q2
$0 Buy
183
+145
+382% +$117 ﹤0.01% 8726
2020
Q1
$0 Buy
+38
New +$54 ﹤0.01% 8593
2017
Q3
Sell
-175
Closed 6962
2017
Q2
$0 Sell
175
-325
-65% -$691 ﹤0.01% 7108
2017
Q1
$1K Buy
+500
New +$1.8K ﹤0.01% 5917
2016
Q3
Sell
-303
Closed -$697 6750
2016
Q2
$0 Buy
+303
New +$618 ﹤0.01% 6712
2016
Q1
Sell
-687
Closed -$1.55K 6547
2015
Q4
$2K Buy
+687
New +$3.29K ﹤0.01% 4661
2015
Q2
Sell
-979
Closed -$6.6K 6111
2015
Q1
$6K Buy
+979
New +$7.38K ﹤0.01% 3414

Simplex Trading's GEN Position: Q2 2021 in Review

Simplex Trading sold out of Genesis Healthcare, Inc. (GEN) in Q2 2021, closing a stake of 4,700 shares — an estimated $1K sold.

Simplex Trading first reported a position in GEN in Q1 2015 and held it in 10 quarters. The position peaked at $6K in Q1 2015. 1 fund tracked by Wall St. Rank holds GEN as of Q2 2021.

  • Simplex Trading reported no remaining Genesis Healthcare, Inc. position as of Q2 2021 after selling out during the quarter.
  • Simplex Trading sold 4,700 Genesis Healthcare, Inc. shares in Q2 2021, an estimated $1K.
  • Simplex Trading first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 10 quarters.
  • Simplex Trading's Genesis Healthcare, Inc. position peaked at $6K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.